A sensitive and high throughput TaqMan-based reverse transcription quantitative polymerase chain reaction assay efficiently discriminates ALK rearrangement from overexpression for lung cancer FFPE specimens. (April 2016)
- Record Type:
- Journal Article
- Title:
- A sensitive and high throughput TaqMan-based reverse transcription quantitative polymerase chain reaction assay efficiently discriminates ALK rearrangement from overexpression for lung cancer FFPE specimens. (April 2016)
- Main Title:
- A sensitive and high throughput TaqMan-based reverse transcription quantitative polymerase chain reaction assay efficiently discriminates ALK rearrangement from overexpression for lung cancer FFPE specimens
- Authors:
- Lung, Jrhau
Lin, Yu-Ching
Hung, Ming-Szu
Jiang, Yuan Yuan
Lee, Kuan-Der
Lin, Paul Yann
Tsai, Ying Huang - Abstract:
- Highlights: A sensitive and high throughput TaqMan based ALK qPCR assay was established. High concordance between qPCR, FISH and IHC based ALK tests. The qPCR assay can efficiently discriminate ALK rearrangement from overexpression. The qPCR assay helps clarify the discrepancies between ALK FISH and IHC results. Abstract: Objectives: ALK fusion gene is an oncogenic driver in lung cancer with low prevalence, which can be ameliorated by crizotinib. Currently, ALK fusion gene can be diagnosed by fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC), but inconstistnt results between the two methods are encountered regularly. To make the ALK fusion gene screening more efficient and to provide a simple solution to clarify the discrepancy between FISH and IHC results, a sensitive TaqMan-based reverse transcription quantitative polymerase chain reaction (RT-qPCR) assay was established. Materials and methods: The 3-plex TaqMan-based RT-qPCR assay was established and performed on 102 archived formalin-fixed, paraffin-embedded (FFPE) NSCLC samples to detect ALK rearrangement and overexpression. Break-apart FISH and automatic immunohistochemistry based ALK assays were performed side by side using tissue microarray. Results: The RT-qPCR was performed successfully for 80 samples and 10 of them showed positive signals. Three out of the 10 qPCR positive cases were further confirmed by FISH and IHC test. Two others were IHC positive and FISH negative, and expressedHighlights: A sensitive and high throughput TaqMan based ALK qPCR assay was established. High concordance between qPCR, FISH and IHC based ALK tests. The qPCR assay can efficiently discriminate ALK rearrangement from overexpression. The qPCR assay helps clarify the discrepancies between ALK FISH and IHC results. Abstract: Objectives: ALK fusion gene is an oncogenic driver in lung cancer with low prevalence, which can be ameliorated by crizotinib. Currently, ALK fusion gene can be diagnosed by fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC), but inconstistnt results between the two methods are encountered regularly. To make the ALK fusion gene screening more efficient and to provide a simple solution to clarify the discrepancy between FISH and IHC results, a sensitive TaqMan-based reverse transcription quantitative polymerase chain reaction (RT-qPCR) assay was established. Materials and methods: The 3-plex TaqMan-based RT-qPCR assay was established and performed on 102 archived formalin-fixed, paraffin-embedded (FFPE) NSCLC samples to detect ALK rearrangement and overexpression. Break-apart FISH and automatic immunohistochemistry based ALK assays were performed side by side using tissue microarray. Results: The RT-qPCR was performed successfully for 80 samples and 10 of them showed positive signals. Three out of the 10 qPCR positive cases were further confirmed by FISH and IHC test. Two others were IHC positive and FISH negative, and expressed full-length ALK transcript. The rest were neither FISH nor IHC positive and their ALK expression level was significantly lower than those FISH or IHC positive cases. Conclusion: Our RT-qPCR assay demonstrates that the capability and reliability of ALK detection is comparable to FISH and IHC, but it is more effective at discriminating ALK rearrangement from overexpression. The RT-qPCR assay easily clarifies the discrepancy between FISH and IHC, and can be incorporated into routine ALK screening for lung cancer. … (more)
- Is Part Of:
- Lung cancer. Volume 94(2016)
- Journal:
- Lung cancer
- Issue:
- Volume 94(2016)
- Issue Display:
- Volume 94, Issue 2016 (2016)
- Year:
- 2016
- Volume:
- 94
- Issue:
- 2016
- Issue Sort Value:
- 2016-0094-2016-0000
- Page Start:
- 114
- Page End:
- 120
- Publication Date:
- 2016-04
- Subjects:
- Lung cancer -- Anaplastic lymphoma kinase -- Real time PCR -- FISH -- Immunohistochemisty
Lungs -- Cancer -- Periodicals
Lung Neoplasms -- Abstracts
Lung Neoplasms -- Periodicals
Poumons -- Cancer -- Périodiques
Lungs -- Cancer
Periodicals
Electronic journals
Electronic journals
616.99424 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01695002 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01695002 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01695002 ↗
http://www.lungcancerjournal.info/issues ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.lungcan.2016.02.004 ↗
- Languages:
- English
- ISSNs:
- 0169-5002
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5307.245000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 1518.xml